Literature DB >> 10979347

Drug-related cardiac iatrogenic illness as the cause for admission to the intensive cardiac care unit.

H Hammerman1, M Kapeliovich.   

Abstract

BACKGROUND: Iatrogenic illness, defined as a disease that results from a diagnostic procedure or from any form of therapy, is a well-recognized phenomenon in clinical practice.
OBJECTIVES: To study and evaluate major cardiac iatrogenic disease as the cause of admission to the intensive cardiac care unit in the modern era.
METHODS: We assessed 64 critically ill patients suffering from major cardiac iatrogenic problems among a total of 2,559 patients admitted to the intensive cardiac care unit during 3 years. Iatrogenic illness was defined as any problem that resulted from therapy. Only cardiac problems were included in the study. Complications of interventional cardiovascular procedures, suicide attempts or accidental intoxications were excluded.
RESULTS: There was evidence of a major cardiac iatrogenic problem as the cause for admission in 64 patients (2.5%): 58 (91%) suffered from arrhythmias (mainly bradyarrhythmias) secondary to beta-blockers, amiodarone, calcium antagonists, electrolyte imbalance or a combination, and 6 (9%) had non-arrhythmic events (hypotension, syncope or acute heart failure). In 41 patients (64%) the iatrogenic event was considered preventable.
CONCLUSIONS: Major cardiac iatrogenic complications are an important factor among patients admitted to the intensive cardiac care unit. Most of the events are bradyarrhythmias related to anti-arrhythmic agents. Almost two-thirds of events are preventable.

Entities:  

Mesh:

Year:  2000        PMID: 10979347

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

1.  Iatrogenic events contributing to ICU admission: a prospective study.

Authors:  Emmanuelle Mercier; Bruno Giraudeau; Guy Giniès; Dominique Perrotin; Pierre-François Dequin
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

Review 2.  A systematic review of adult admissions to ICUs related to adverse drug events.

Authors:  Pierre-Alain Jolivot; Patrick Hindlet; Claire Pichereau; Christine Fernandez; Eric Maury; Bertrand Guidet; Gilles Hejblum
Journal:  Crit Care       Date:  2014-11-25       Impact factor: 9.097

3.  Beta-blocker use and risk of symptomatic bradyarrhythmias: a hospital-based case-control study.

Authors:  Hou Tee Lu; Jiyen Kam; Rusli Bin Nordin; Surinder Kaur Khelae; Jing Mein Wang; Chun Ngok Choy; Chuey Yan Lee
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

4.  Beta-Blocker-Related Atrioventricular Conduction Disorders-A Single Tertiary Referral Center Experience.

Authors:  Dragoș Traian Marius Marcu; Cristina Andreea Adam; Dan-Mihai Dorobanțu; Delia Lidia Șalaru; Radu Andy Sascău; Mircea Ovanez Balasanian; Liviu Macovei; Cătălina Arsenescu-Georgescu; Cristian Stătescu
Journal:  Medicina (Kaunas)       Date:  2022-02-20       Impact factor: 2.430

5.  An observational study of adult admissions to a medical ICU due to adverse drug events.

Authors:  Pierre-Alain Jolivot; Claire Pichereau; Patrick Hindlet; Gilles Hejblum; Naïke Bigé; Eric Maury; Bertrand Guidet; Christine Fernandez
Journal:  Ann Intensive Care       Date:  2016-02-02       Impact factor: 6.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.